Yonatan Malca - 01 Jan 2022 Form 4 Insider Report for Entera Bio Ltd. (ENTX)

Reporting relationship
Director
Issuer ticker
ENTX
Reported as of
01 Jan 2022
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
14 Jan 2022, 06:06:45 UTC
Next SEC filing
18 Jan 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Dana Yaacov-Garbeli , Attorney-in-Fact
Filing notes and source

Key filing fact

Yonatan Malca filed Form 4 for Entera Bio Ltd. (ENTX) on 14 Jan 2022.

Key facts

  • This page summarizes Yonatan Malca's Form 4 filing for Entera Bio Ltd. (ENTX).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 14 Jan 2022, 06:06.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ENTX transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+35,852
Change %
Price
$0.000000
Shares after
35,852
Date
01 Jan 2022
Ownership
Direct
Underlying class
Ordinary Shares, par value NIS 0.0000769 per share
Underlying amount
35,852
Exercise price
$2.82
Footnotes
F1
ENTX transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+107,557
Change %
Price
$0.000000
Shares after
107,557
Date
01 Jan 2022
Ownership
Direct
Underlying class
Ordinary Shares, par value NIS 0.0000769 per share
Underlying amount
107,557
Exercise price
$2.82
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2022.

Footnote F2

The options vest ratably on a quarterly basis over a three-year period that commenced on January 1, 2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .